Back to Search
Start Over
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.
- Source :
-
The Canadian journal of cardiology [Can J Cardiol] 2017 May; Vol. 33 (5), pp. 557-576. Date of Electronic Publication: 2017 Mar 10. - Publication Year :
- 2017
-
Abstract
- Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis, assessment, prevention, and treatment of hypertension. This year, we introduce 10 new guidelines. Three previous guidelines have been revised and 5 have been removed. Previous age and frailty distinctions have been removed as considerations for when to initiate antihypertensive therapy. In the presence of macrovascular target organ damage, or in those with independent cardiovascular risk factors, antihypertensive therapy should be considered for all individuals with elevated average systolic nonautomated office blood pressure (non-AOBP) readings ≥ 140 mm Hg. For individuals with diastolic hypertension (with or without systolic hypertension), fixed-dose single-pill combinations are now recommended as an initial treatment option. Preference is given to pills containing an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in combination with either a calcium channel blocker or diuretic. Whenever a diuretic is selected as monotherapy, longer-acting agents are preferred. In patients with established ischemic heart disease, caution should be exercised in lowering diastolic non-AOBP to ≤ 60 mm Hg, especially in the presence of left ventricular hypertrophy. After a hemorrhagic stroke, in the first 24 hours, systolic non-AOBP lowering to < 140 mm Hg is not recommended. Finally, guidance is now provided for screening, initial diagnosis, assessment, and treatment of renovascular hypertension arising from fibromuscular dysplasia. The specific evidence and rationale underlying each of these guidelines are discussed.<br /> (Copyright © 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Adult
Blood Pressure drug effects
Canada epidemiology
Comorbidity
Female
Humans
Male
Medication Therapy Management standards
Middle Aged
Risk Assessment methods
Antihypertensive Agents classification
Antihypertensive Agents therapeutic use
Blood Pressure Determination methods
Diuretics classification
Diuretics therapeutic use
Hypertension diagnosis
Hypertension drug therapy
Hypertension epidemiology
Hypertension prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1916-7075
- Volume :
- 33
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The Canadian journal of cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 28449828
- Full Text :
- https://doi.org/10.1016/j.cjca.2017.03.005